1976
DOI: 10.1182/blood.v48.4.491.bloodjournal484491
|View full text |Cite
|
Sign up to set email alerts
|

Establishment of erythropoiesis following bone marrow transplantation in a patient with congenital hypoplastic anemia (Diamond-Blackfan syndrome)

Abstract: Marrow transplantation was attempted in a 13-yr-old boy with congenital hypoplastic anemia who had never responded to corticosteroid therapy. Prior to the transplant, he had received 238 transfusions, at least 12 of which were from his father. He was prepared for grafting with antilymphocyte globulin, procarbazine, and total body irradiation (1000 rads). The patient, whose red cells were Group B, then received marrow cells from his Group O, histocompatible, sister. Thereafter, reticulocytes, Group O erythrocyt… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
2
0

Year Published

2010
2010
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…In 1951, corticosteroids were first reported to show therapeutic effects by Gasser [ 8 ], followed by a study of Diamond et al indicating that a group of patients could respond to corticosteroid therapy [ 9 ]. In 1976, the first known bone marrow transplantation was performed on a 13-year-old boy with DBA who never responded to corticosteroid therapy and had received 238 transfusions, but iron chelation therapy showed no effects [ 10 ]. Initially, the treatment progressed well with erythroid precursors production was detected in the patient’s marrow for the first time in his life.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…In 1951, corticosteroids were first reported to show therapeutic effects by Gasser [ 8 ], followed by a study of Diamond et al indicating that a group of patients could respond to corticosteroid therapy [ 9 ]. In 1976, the first known bone marrow transplantation was performed on a 13-year-old boy with DBA who never responded to corticosteroid therapy and had received 238 transfusions, but iron chelation therapy showed no effects [ 10 ]. Initially, the treatment progressed well with erythroid precursors production was detected in the patient’s marrow for the first time in his life.…”
Section: Introductionmentioning
confidence: 99%
“…Initially, the treatment progressed well with erythroid precursors production was detected in the patient’s marrow for the first time in his life. However, the patient developed interstitial pneumonia and died 55 days after the transplant [ 10 ]. Elevated erythrocyte adenosine deaminase activity (eADA) in DBA patients was first reported and suggested as a marker for DBA by Diamond et al in 1983 [ 11 ].…”
Section: Introductionmentioning
confidence: 99%
“…Allogeneic HCT remains the only option for hematopoietic cure in patients with DBA. The first HCT for DBA was performed in 1976, proving that hematological cure is possible (35). Numerous case reports since then confirmed the feasibility of HCT in DBA.…”
Section: Transplant Indications and Outcomesmentioning
confidence: 99%